1

Sinha PK, Griensven JV, Pandey K, Kumar N, Verma N, Mahajan R, Kumar P, Kumar R, Das P, Mitra G, Flevaud L, Ferreyra C, Remartinez D, Pece M and Palma PP. Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India. Clin Infect Dis., 2011; 53(7): e91-e98. (doi:10.1093/cid/cir521)

2

Sundar S, Sinha PK, Dixon SA, Buckley R, Miller AK, Mohamed K and Al-Banna M. Pharmacokinetics of Oral Sitamaquine Taken with or without Food and Safety and Efficacy for Treatment of Visceral Leishmaniais: A Randomized Study in Bihar, India. Am J Trop Med Hyg., 2011; 84(6): 892-900.

3

Sinha PK and Battacharya SK. Antimicrobial resistance in Leishmania donovani in Bihar, India. Regional Health Forum, 2011; 15(1): 134.

4

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D and Alvar J. Visceral leishmaniasis: elimination with existing interventions. The Lancet Infectious Diseases, 2011; 11(4): 322 – 325.

5

Sundar S, Sinha PK, Rai M, Verma DK, Nawin K, Alam S, Chakravarty J, Vaillant M, Verma N, Pandey K, Kumari P, Lal CS, Arora R, Sharma B, Ellis S, Strub-Wourgaft N, Balasegaram M, Olliaro P, Das P and Modabber F. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet, 2011; 377(9764): 477-486. (Epub 2011 Jan 20)

6

Sundar S, Sinha PK, Verma DK, Kumar N, Alam S, Pandey K, Kumari P, Ravidas V, Chakravarty J, Verma N, Berman J, Ghalib H and Arana B. Ambisome plus miltefosine for Indian patients with kala-azar. Trans R Soc Trop Med Hyg, 2011;105(2): 115-7 (Epub 2010 Dec 3).

7

Sinha PK, Roddy P, Palma PP, Kociejowski A, Lima MA, Rabi Das VN, Gupta J, Kumar N, Mitra G, Saint-Sauveur JF, Seena S, Balasegaram M, Parreño F and Pandey K. Effectiveness and Safety of Liposomal Amphotericin B for Visceral Leishmaniasis under Routine Program Conditions in Bihar, India. Am J Trop Med Hyg. 2010; 83(2): 357-364.

8 

Das VN, Siddiqui NA, Pandey K, Singh VP, Topno RK, Singh D, Verma RB, Ranjan A, Sinha PK and Das P. A controlled, randomized nonblinded clinical trial to assess the effi cacy of amphotericin B deoxycholate as compared to pentamidine for the treatment of antimony unresponsive visceral leishmaniasis cases in Bihar, India. Therapeutics and Clinical Risk Management, 2009; 5: 117–124.

9 

Narayan S, Bimal S, Singh SK, Gupta AK, Singh VP, Sinha PK and Das P. Leishmania donovani vs Immunity: T-cells sensitized from Leishmaniaof one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis. Experimental Parasitology, 2009; 121: 69-75.

10

Pandey K, Sinha PK, Das VN, Bimal S, Singh SK and Das P. Pharmacotherapeutic Options for Visceral Leishmaniasis—Current Scenario. Clinical Medicine: Pathology, 2009; 2: 1–4.

11

Pandey K, Sinha PK, Das VN, Nawin Kumar, Bimal S, Verma RB, Verma N, Lal CS, Topno RK, Siddiqui NA, Singh D and Das P. Tuberous sclerosis with visceral leishmaniasis: a case report. Journal of Medical Case Reports, 2009; 3: 9027.

12

Bimal S, Singh SK, Sinha S, Pandey K, Sinha PK, Ranjan A, Bhattacharya SK and Das P. Leishmania donovani: Role of CD2 on CD4+ T – cell function in Visceral leishmaniasis. Exp. Parasitol., 2008; 118(2): 238-246.

13

Sinha PK, Bimal S, Pandey K, Singh SK, Ranjan A, Kumar N, Lal CS, Barman SB, Verma RB, Jeyakumar A, Das P, Bhattacharya M, Sur D and Bhattacharya SK. A community-based, comparative evaluation of direct agglutination and rK39 strip tests in the early detection of subclinical Leishmania donovani infection. Ann. Trop. Med. & Parasitol, (2008); 102(2): 119-125.

14

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Lal CS, Bimal S, Verma N and Das P. HIV infection, visceral leishmaniasis and Guillain –Barre syndrome in same patient: a case report. Ann. Trop. Med. & Parasitol., 2008; 102(2): 185-188.

15

Mookerjee Basu J, Mookerjee A, Banerjee R, Saha M, Singh S, Naskar K, Tripathy G, Sinha PK, Pandey K, Sundar S, Bimal S, Pradeep Das, Choudhuri SK and Roy S. Inhibition of ABC Transporters Abolishes Antimony Resistance in Leishmania Infection. Antimicrob Agents Chemother., 2008; 52(3): 1080-1093.

16

Topno RK, Pandey K, Das VN, Kumar N, Bimal S, Verma RB, Siddiqui NA, Singh D, Kumar R, Kumar P, Ranjan A, Das P and Sinha PK. Visceral Leishmaniasis in pregnancy – role of Amphotericin B. Ann. Trop. Med. & Parasitol, 2008; 102(3): 267-270.

17

Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, Bhattacharya SK and Sinha A. Impact of Ampotericin B in the treatment of Kalaazar on the incidence of PKDL in Bihar, India. Indian Journal of Medical Research, 2008; 128: 38-44.

18

Pandey K, Sinha PK, Rabidas V, Kumar N, Bimal S, Verma N, Lal C and Das P. HIV, visceral leishmaniasis and Parkinsonism combined with diabetes mellitus and hyperuricaemia: A case report. Cases Journal, 2008; 1: 183.

19

Narayan S, Gupta AK, Singh Subhankar K, Lal CS, Singh VP, Sinha PK, Das P and Thakur CP. Clinical and Laboratory comparision of different brands of Amphotericin B used for the treatment of kala-azar. Journal of Communicable Diseases, 2008; 40(4): 273-276.

20

Muniaraj M, Lal CS, Kumar S, Sinha PK and Das P. Milk of cow (Bos taurus), buffalo (Bubalus bubalis), and goat (Capra hircus): a better alternative than fetal bovine serum in media for primary isolation, in vitro cultivation, and maintenance of Leishmania donovani promastigotes.  J. Clin. Microbiol. 2007; 45(4): 1353-1356.

21

Kumar N, Pandey K, Das VN, Sinha PK, Topno RK, Verma N, Lal CS, Das P and Bhattacharya SK. Miltefosine in the Treatment of a case of Visceral Leishmaniasis with Renal Dysfunction. Ann Trop Med Parasitol., 2007; 101(7): 649-651.

22 

Bhattacharya SK, Sinha PK, Sundar S, Thakur CP, Jha TK, Pandey K, Das VR, Kumar N, Lal C, Verma N, Singh VP, Ranjan A, Verma RB, Anders G, Sindermann H and Ganguly NK. Phase IV Trial of Miltefosine in the Treatment of Indian Visceral Leishmaniasis. J Infect Dis. 2007; 196(4): 591-598.

23

Sundar S, Jha TK, Thakur CP, Sinha PK and Bhattacharya SK. Injectable paromomycin for Visceral Leishmaniasis in India. The New England Journal of Medicine, 2007; 356(25): 71-81.

24 

Lal CS, Kumar A, Kumar S, Pandey K, Kumar N, Bimal S, Sinha PK and Das P. Hypocholesterolemia and increased triglycerides in paediatric visceral leishmaniasis. Clinica Chimica Acta, 2007; 382(1-2): 151-153.

25

Pandey K, Sinha PK, Das VN, Kumar N, Verma N, Bimal S, Lal CS, Topno RK, Singh D, Verma RB, Bhattacharya SK and Das P. Wilson Disease with Visceral Leishmaniasis: An Extremely Uncommon Presentation. Am J Trop Med Hyg. 2007; 77(3): 560 – 561.

26

Bhattacharya SK, Sur D, Sinha PK, Karbwang J. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable. Indian J Med Res., 2006; 123:195-196.

27

Muniaraj M, Gupta AK, Narayan S, Singh D, Sinha PK, Das P. Long-term preservation of Leishmania donovani promastigotes on blood-agar slants, Ann Trop Med Parasitol. 2006; 100(2): 173-175.

28

Sinha PK, Bimal S, Singh SK, Pandey K, Gangopadhyay DN, And Bhattacharya SK. Pre and Post Treatment evaluation of Immunological features in Indian Visceral Leishmaniasis patient with HIV Co-Infection. Indian J Med Res., 2006; 123: 197-202.

29

Sinha PK, Ranjan A, Singh VP, Das VNR, Pandey K, Kumar N, Verma N, Lal CS, Sur D, Manna B and Bhattacharya SK. Visceral Leishmaniasis (Kala-azar)-the Bihar (India) perspective. J Infect. 2006; 53(1): 60-64.

30

Pranati, Bimal S, Pandey K, Sinha PK, Gupta AK, Singh SK, Sundaram S and Das P. Leishmania donovani: Immunomodulatory Role of 63KDa Leishmania Antigen in the Promotion of IFN-gamma Response (VL vs HIV-VL Co-infection). Am. J. Immunol., 2006; 2(2): 52-57.

31

Das VN, Ranjan A, Bimal S, Siddique NA, Pandey K, Kumar N, Verma N, Singh VP, Sinha PK and Bhattacharya SK. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar. Natl Med J India, 2005; 18(3): 131-133.

32

Bimal S, Das VN, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Sen A, Bhattacharya SK and Das P. Usefulness of the direct agglutination test in the early detection of subclinical L.  donovani infection: a community-based study. Ann. Trop. Med. & Parasitol., 2005; 99: 743-749.

33

Bimal S, Singh SK, Das VN, Sinha PK, Gupta AK, Bhattacharya SK and Das P. Leishmania donovani: effect of therapy on expression of CD2 antigen and secretion of macrophage migration inhibition factor by T-cells in patients with visceral leishmaniasis. Exp Parasitol. 2005; 111(2): 130-132.

34

Muniaraj M, Gupta AK, Narayan S, Kumar S, Sinha PK, Kishore K and Das P. Removal of bacterial and yeast contamination from Leishmania promastigote cultures, by agar plating. Ann Trop Med Parasitol. 2005; 99(6): 617-621.

35

Muniaraj M, Gupta AK, Narayan S, Singh D, Sinha PK, Kishore K, Das P and Bhattacharya SK. Preservation of Leishmania donovani promastigotes in blood agar slants. Journal of communicable Diseases. 2005; 37(3): 191-195.

36

Pandey K, Sinha PK, Das VN, Kumar N, Hassan SM, Verma N, Lal CS, Bimal S, Das P and Bhattacharya SK. HIV-I infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient- a case report. Ann Trop Med Parasitol. 2005; 99(8): 807-811.

37

Sinha PK, Pandey K and Bhattacharya SK. Diagnosis & Management of Leishmania/ HIV Co-Infection. Indian J Med Res., 2005; 121: 407-414.

38

Ranjan A, Sur D, Singh VP, Siddique NA, Manna B, Lal CS, Sinha PK, Kishore K and Bhattacharya SK. Risk factors for Indian Kala–Azar. Am J Trop Med Hyg. 2005; 73(1): 74-78.

39

Pandey K, Sinha PK, Das VNR, Sur D, Kumar Nawin, and Bhattacharya SK. Neurocysticercosis in a Patient With Visceral Leishmaniasis Co-infected With HIV: A Case Report. Infectious Disease in Clinical Practice. 2005; 13(3): 1-2.

40

Bimal S,  Singh S, Pandey K, Sinha PK, Das PK, Schallig H, Das P and Bhattacharya SK. Comparative evaluation of aqueous and freeze dried antigen for Sero-diagnosis of VL and PKDL cases by DAT. American Journal of Immunology, 2005; 1(2): 74-78.

41

Singh SK, Bimal S, Dinesh DS, Gupta AK, Sinha PK, Bimal R and Das P. Towards identifying immunogenic targets in visceral leishmaniasis: role of 17 kDa and 63 kDa phosphoproteins. American Journal of Infectious Diseases, 2005; 1 (3): 94-98.

42

Singh SK, Bimal S, Dinesh DS, Gupta AK, Sinha PK, Bimal R and Das P. Towards Identifying Immunogenic Targets in Visceral Leishmaniasis: Role of 17kDa and 63kDa Phosphoproteins. American Journal of Immunology. 2005; 1(3): 96-100.

43

Bimal S, Das VNR, Sinha PK, Gupta AK, Verma N, Ranjan A, Singh SK, Bhattacharya SK and Pas P. Relevance of direct agglutination test for detection of sub-clinical infection among contacts of kala-azar and non- kala-azar households. J Immunol Immunopathol. 2004; 6(S-1): 85.      

44

Sinha PK, Rabidas VN, Pandey K, Verma N, Gupta AK, Ranjan A, Das P and Bhattacharya SK. Visceral Leishmaniasis and HIV Coinfection in Bihar, India. Letter to Editor, J Acquire Immune Defic Syndr. 2003; 32(1): 115-116.

45

Sinha PK, Ranjan A, Siddique NA, Anil CK, Priya A, Das P and Bhattacharya SK. Usefulness of voluntary counseling and testing center for HIV/AIDS: Bihar as an example.J Acquir Immune Defic Syndr. 2003; 33(3): 407-408.

46

Bimal S, Bagchi AK, Das V, Sinha PK, Lal CS, Ranjan A, Gupta AK and Kar SK. Effect of immunization with lipid associated polysaccharide antigen and anti CD-2 antibodies on class II MHC expression and cellular immune response in BALB/C mice infected with leishmania donovani. Indian Journal of Experimental Biology, 2001; 39: 878-882.

47

Thakur CP, Sinha PK, Singh RK, Hassan SM and Narain S. Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India. Trans R Soc Trop Med Hyg, 2000; 94(6): 696-697

48

Thakur CP, Sinha GP, Sharma V, Pandey AK, Sinha PK and Barat D. Efficacy of Amphotericin B in Multi drug resistant kala-azar in children in first decade of life. Indian Journal of Paediatric, 1993; 60(1): 29-36.

49

Thakur CP, Sinha G, Pandey AK, Barat D and Sinha PK. Amphotericin-B in resistant Kala-azar in Bihar. The National Medical Journal of India, 1993; 6(2): 57-60.

50

Thakur CP and Sinha PK. Inefficacy of ethambutol, ethambutol plus isoniazid, INH plus rifampicin, co-trimoxazole and metronidazole in the treatment of kala-azar. Journal of Tropical Medicine & Hygiene, 1989; 92: 383-385.

51

Thakur CP, Thakur B, Singh S, Sinha PK and Sinha SK. The Ayurvedic Medicine Haritaki, Amla & Balvira reduce Cholestrol induced Atherosclerosis in Rabbits. International Journal of Cardilogy, 1988; 21:167-175.

52

Thakur CP, Kumar K, Sinha PK, Mishra BN and Pandey AK. Treatment of Post Kala-azar Dermal Leishmaniasis with Sodium Stibogluconate. Br Med J (Clin Res Ed), 1987; 295(6603): 886–887.